{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:51:44Z","timestamp":1761709904833,"version":"3.41.2"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002770","name":"Cabinet Office, Government of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Interstitial lung diseases (ILDs) are a group of respiratory disorders characterized by chronic inflammation and fibrosis of the pulmonary interstitial tissues. Although the etiology of ILD remains unclear, some drug treatments are among the primary causes of ILD. In the present study, we analyzed the FDA Adverse Event Reporting System and JMDC Inc. insurance claims to identify a coexisting drug that reduced the incidence of ILD associated with the use of an anti-arrhythmic agent, amiodarone, and found that the thrombin inhibitor dabigatran prevented the amiodarone-induced ILD in both clinical datasets. In an experimental validation of the hypothesis, long-term oral treatment of mice with amiodarone caused a gradual decrease in body weight caused by respiratory insufficiency. In the lungs of amiodarone-treated mice, infiltration of macrophages was observed in parallel with a delayed upregulation of the platelet-derived growth factor receptor \u03b1 gene. In contrast, co-treatment with dabigatran significantly attenuated these amiodarone-induced changes indicative of ILD. These results suggest that dabigatran is effective in preventing drug-induced ILD. This combinatorial approach of drug repurposing based on clinical big data will pave the way for finding a new treatment with high clinical predictability and a well-defined molecular mechanism.<\/jats:p>","DOI":"10.3389\/fphar.2021.635293","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T06:44:24Z","timestamp":1632206664000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Drug Repurposing Prediction and Validation From Clinical Big Data for the Effective Treatment of Interstitial Lung Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Soni","family":"Siswanto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mone","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Kayanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Nagayasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"160026","DOI":"10.1038\/sdata.2016.26","article-title":"A Curated and Standardized Adverse Drug Event Resource to Accelerate Drug Safety Research","volume":"3","author":"Banda","year":"2016","journal-title":"Sci. Data"},{"key":"B2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/jcm7080201","article-title":"Idiopathic Pulmonary Fibrosis (IPF): an Overview","volume":"7","author":"Barratt","year":"2018","journal-title":"J. Clin. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/art.30255","article-title":"Antiinflammatory and Antifibrotic Effects of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in a Murine Model of Interstitial Lung Disease","volume":"63","author":"Bogatkevich","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1002\/art.24935","article-title":"Dabigatran, a Direct Thrombin Inhibitor, Demonstrates Antifibrotic Effects on Lung Fibroblasts","volume":"60","author":"Bogatkevich","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pupt.2018.07.002","article-title":"Use of Animal Models in IPF Research","volume":"51","author":"Carrington","year":"2018","journal-title":"Pulm. Pharmacol. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"S367","DOI":"10.1038\/sj.bjp.0707603","article-title":"Procoagulant Signalling Mechanisms in Lung Inflammation and Fibrosis: Novel Opportunities for Pharmacological Intervention?","author":"Chambers","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/path.1711440202","article-title":"Amiodarone Lung Toxicity: a Human and Experimental Study","volume":"144","author":"Costa-Juss\u00e0","year":"1984","journal-title":"J. Pathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.30802\/AALAS-CM-18-000060","article-title":"Monitoring the Health Status of Mice with Bleomycin-Induced Lung Injury by Using Body Condition Scoring","volume":"69","author":"Cowley","year":"2019","journal-title":"Comp. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fmed.2018.00043","article-title":"The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis","volume":"5","author":"Desai","year":"2018","journal-title":"Front. Med. (Lausanne)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","article-title":"Mapping Identifiers for the Integration of Genomic Datasets with the R\/Bioconductor Package biomaRt","volume":"4","author":"Durinck","year":"2009","journal-title":"Nat. Protoc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.imbio.2012.10.004","article-title":"Platelet Derived Growth Factor-CC Secreted by M2 Macrophages Induces Alpha-Smooth Muscle Actin Expression by Dermal and Gingival Fibroblasts","volume":"218","author":"Glim","year":"2013","journal-title":"Immunobiology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/S0002-9440(10)62525-4","article-title":"Direct Thrombin Inhibition Reduces Lung Collagen, Accumulation, and Connective Tissue Growth Factor mRNA Levels in Bleomycin-Induced Pulmonary Fibrosis","volume":"159","author":"Howell","year":"2001","journal-title":"Am. J. Pathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S0002-9440(10)62354-1","article-title":"Absence of Proteinase-Activated Receptor-1 Signaling Affords protection from Bleomycin-Induced Lung Inflammation and Fibrosis","volume":"166","author":"Howell","year":"2005","journal-title":"Am. J. Pathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1248\/bpb.b19-00929","article-title":"Drug Repositioning and Target Finding Based on Clinical Evidence","volume":"43","author":"Kaneko","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"B15","doi-asserted-by":"publisher","first-page":"12569","DOI":"10.1038\/s41598-017-12849-8","article-title":"Drug Repurposing in Idiopathic Pulmonary Fibrosis Filtered by a Bioinformatics-Derived Composite Score","volume":"7","author":"Karatzas","year":"2017","journal-title":"Sci. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a Fast Spliced Aligner with Low Memory Requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"key":"B17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mam.2017.11.008","article-title":"PDGF in Organ Fibrosis","volume":"62","author":"Klinkhammer","year":"2018","journal-title":"Mol. Aspects Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10654-017-0281-8","article-title":"Sequence Symmetry Analysis in Pharmacovigilance and Pharmacoepidemiologic Studies","volume":"32","author":"Lai","year":"2017","journal-title":"Eur. J. Epidemiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast Gapped-Read Alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"B20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: Accurate Transcript Quantification from RNA-Seq Data with or without a Reference Genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/jth.13623","article-title":"Targeting Coagulation Factor Receptors - Protease-Activated Receptors in Idiopathic Pulmonary Fibrosis","volume":"15","author":"Lin","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1021\/acs.jmedchem.6b01507","article-title":"Drug Repurposing of Histone Deacetylase Inhibitors that Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis","volume":"60","author":"Lu","year":"2017","journal-title":"J. Med. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cyto.2014.11.008","article-title":"The Cytokines of Pulmonary Fibrosis: Much Learned, Much More to Learn","volume":"74","author":"Luzina","year":"2015","journal-title":"Cytokine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"115272","DOI":"10.1016\/j.taap.2020.115272","article-title":"Pulmonary Toxicants and Fibrosis: Innate and Adaptive Immune Mechanisms","volume":"409","author":"Malaviya","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"26375","DOI":"10.1038\/srep26375","article-title":"Prevention of Antipsychotic-Induced Hyperglycaemia by Vitamin D: a Data Mining Prediction Followed by Experimental Exploration of the Molecular Mechanism","volume":"6","author":"Nagashima","year":"2016","journal-title":"Sci. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1164\/rccm.201202-0314oc","article-title":"A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis","volume":"186","author":"Noth","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1165\/ajrcmb.10.4.7510986","article-title":"Scleroderma Bronchoalveolar Lavage Fluid Contains Thrombin, a Mediator of Human Lung Fibroblast Proliferation via Induction of Platelet-Derived Growth Factor Alpha-Receptor","volume":"10","author":"Ohba","year":"1994","journal-title":"Am. J. Respir. Cel Mol. Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","article-title":"Drug Repurposing: a Promising Tool to Accelerate the Drug Discovery Process","volume":"24","author":"Parvathaneni","year":"2019","journal-title":"Drug Discov. Today"},{"key":"B29","doi-asserted-by":"publisher","first-page":"S263","DOI":"10.1038\/sj.bjp.0707507","article-title":"Proteinases and Signalling: Pathophysiological and Therapeutic Implications via PARs and More","volume":"153","author":"Ramachandran","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/database\/baw100","article-title":"The Harmonizome: a Collection of Processed Datasets Gathered to Serve and Mine Knowledge about Genes and Proteins","volume":"2016","author":"Rouillard","year":"2016","journal-title":"Database (Oxford)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12931-016-0420-x","article-title":"Metformin Attenuates Lung Fibrosis Development via NOX4 Suppression","volume":"17","author":"Sato","year":"2016","journal-title":"Respir. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1183\/09059180.00001111","article-title":"Antifibrotic Activities of Pirfenidone in Animal Models","volume":"20","author":"Schaefer","year":"2011","journal-title":"Eur. Respir. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e86608","DOI":"10.1172\/jci.insight.86608","article-title":"Uncoupling of the Profibrotic and Hemostatic Effects of Thrombin in Lung Fibrosis","volume":"2","author":"Shea","year":"2017","journal-title":"JCI Insight"},{"key":"B34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/acr2.11049","article-title":"Safety and Tolerability of Thrombin Inhibition in Scleroderma-Associated Interstitial Lung Disease","volume":"1","author":"Silver","year":"2019","journal-title":"ACR Open Rheumatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/jcm7100356","article-title":"Drug-induced Interstitial Lung Disease: a Systematic Review","volume":"7","author":"Skeoch","year":"2018","journal-title":"J. Clin. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1136\/thoraxjnl-2016-208680","article-title":"Repositioning Compounds from Cancer Drug Discovery to IPF: PI3K Inhibition","volume":"71","author":"Staab-Weijnitz","year":"2016","journal-title":"Thorax"},{"key":"B37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00059-014-4188-9","article-title":"Relevance of P-Glycoprotein in Stroke Prevention with Dabigatran, Rivaroxaban, and Apixaban","author":"St\u00f6llberger","year":"2015","journal-title":"Herz"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of Action of Nintedanib in the Treatment of Idiopathic Pulmonary Fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur. Respir. J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1253\/circj.71.1610","article-title":"Incidence and Predictors of Pulmonary Toxicity in Japanese Patients Receiving Low-Dose Amiodarone","volume":"71","author":"Yamada","year":"2007","journal-title":"Circ. J."},{"key":"B40","first-page":"1270","article-title":"Dihydroartemisinin Supresses Inflammation and Fibrosis in Bleomycine-Induced Pulmonary Fibrosis in Rats","volume":"8","author":"Yang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.7150\/ijms.28877","article-title":"Bleeding Risk of Warfarin and Direct Oral Anticoagulants in Younger Population: a Historical Cohort Study Using a Japanese Claims Database","volume":"15","author":"Yokoyama","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"206ra140","DOI":"10.1126\/scitranslmed.3006548","article-title":"Systems Pharmacology of Adverse Event Mitigation by Drug Combinations","volume":"5","author":"Zhao","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"L182","DOI":"10.1152\/ajplung.00083.2003","article-title":"Modulation of PDGF-C and PDGF-D Expression during Bleomycin-Induced Lung Fibrosis","volume":"286","author":"Zhuo","year":"2004","journal-title":"Am. J. Physiol. Lung Cel Mol. Physiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.635293\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T06:44:30Z","timestamp":1632206670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.635293\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":43,"alternative-id":["10.3389\/fphar.2021.635293"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.635293","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2021,9,21]]},"article-number":"635293"}}